First Targeted Therapy For Bowel Cancer Funded In New Zealand From Today: ERBITUX® (cetuximab)
New Zealanders living with a specific type of advanced bowel cancer will be able to access a globally-recognised standard of care treatment, ERBITUX®(cetuximab)[1], that from today is listed on the Pharmaceutical Scheme.
1 Nov 21:32 · SCOOP